JP2019508184A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019508184A5 JP2019508184A5 JP2018548904A JP2018548904A JP2019508184A5 JP 2019508184 A5 JP2019508184 A5 JP 2019508184A5 JP 2018548904 A JP2018548904 A JP 2018548904A JP 2018548904 A JP2018548904 A JP 2018548904A JP 2019508184 A5 JP2019508184 A5 JP 2019508184A5
- Authority
- JP
- Japan
- Prior art keywords
- solution
- self
- assembling peptide
- hydrogel
- assembling
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 58
- 239000000017 hydrogel Substances 0.000 claims description 30
- 238000000034 method Methods 0.000 claims description 30
- 150000001413 amino acids Chemical class 0.000 claims description 25
- 238000002679 ablation Methods 0.000 claims description 8
- 230000015572 biosynthetic process Effects 0.000 claims description 8
- 230000004962 physiological condition Effects 0.000 claims description 8
- 101100271190 Plasmodium falciparum (isolate 3D7) ATAT gene Proteins 0.000 claims description 4
- 239000012867 bioactive agent Substances 0.000 claims description 4
- 239000003814 drug Substances 0.000 claims description 4
- 229940079593 drug Drugs 0.000 claims description 4
- 230000002209 hydrophobic effect Effects 0.000 claims description 4
- 238000001727 in vivo Methods 0.000 claims description 4
- 206010047302 ventricular tachycardia Diseases 0.000 claims description 4
- 210000001072 colon Anatomy 0.000 claims description 3
- 208000000094 Chronic Pain Diseases 0.000 claims description 2
- 208000004483 Dyspareunia Diseases 0.000 claims description 2
- 206010028980 Neoplasm Diseases 0.000 claims description 2
- 208000002193 Pain Diseases 0.000 claims description 2
- 206010041101 Small intestinal obstruction Diseases 0.000 claims description 2
- 238000011538 abdominal hysterectomy Methods 0.000 claims description 2
- 208000000509 infertility Diseases 0.000 claims description 2
- 230000036512 infertility Effects 0.000 claims description 2
- 231100000535 infertility Toxicity 0.000 claims description 2
- 230000036210 malignancy Effects 0.000 claims description 2
- 238000009806 oophorectomy Methods 0.000 claims description 2
- 238000001356 surgical procedure Methods 0.000 claims description 2
- 210000001519 tissue Anatomy 0.000 claims 21
- 102000004196 processed proteins & peptides Human genes 0.000 claims 10
- 239000002904 solvent Substances 0.000 claims 2
- 230000003187 abdominal effect Effects 0.000 claims 1
- 210000004534 cecum Anatomy 0.000 claims 1
- 210000000936 intestine Anatomy 0.000 claims 1
- 210000004197 pelvis Anatomy 0.000 claims 1
- 210000004303 peritoneum Anatomy 0.000 claims 1
- 206010034238 Pelvic adhesions Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662310121P | 2016-03-18 | 2016-03-18 | |
| US201662310131P | 2016-03-18 | 2016-03-18 | |
| US62/310,121 | 2016-03-18 | ||
| US62/310,131 | 2016-03-18 | ||
| PCT/IB2017/000312 WO2017158420A1 (en) | 2016-03-18 | 2017-03-17 | Preventing biological tissue adhesion |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019508184A JP2019508184A (ja) | 2019-03-28 |
| JP2019508184A5 true JP2019508184A5 (enExample) | 2020-04-23 |
| JP7049557B2 JP7049557B2 (ja) | 2022-04-07 |
Family
ID=58645327
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018548904A Active JP7049557B2 (ja) | 2016-03-18 | 2017-03-17 | 生物組織の癒着の予防 |
Country Status (11)
| Country | Link |
|---|---|
| US (4) | US20190091376A1 (enExample) |
| EP (1) | EP3429653B1 (enExample) |
| JP (1) | JP7049557B2 (enExample) |
| KR (1) | KR20190022455A (enExample) |
| CN (1) | CN109152868A (enExample) |
| AU (2) | AU2017232540A1 (enExample) |
| BR (1) | BR112018068941A2 (enExample) |
| CA (1) | CA3017684A1 (enExample) |
| CL (1) | CL2018002646A1 (enExample) |
| MX (1) | MX2018011121A (enExample) |
| WO (1) | WO2017158420A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20190022455A (ko) | 2016-03-18 | 2019-03-06 | 가부시끼가이샤 쓰리디 매트릭스 | 생물학적 조직 유착을 방지하는 방법 |
| JP7442196B2 (ja) | 2018-07-03 | 2024-03-04 | 株式会社スリー・ディー・マトリックス | イオン性自己組織化ペプチド |
| EP4125995A4 (en) | 2020-03-31 | 2024-04-10 | 3-D Matrix, Ltd. | STERILIZATION OF SELF-ASSEMBLY PEPTIDES BY IRRADIATION |
| KR20250155730A (ko) * | 2024-04-24 | 2025-10-31 | 경희대학교 산학협력단 | 하지정맥 수술시 정맥 내벽의 기계 화학적 절제장치 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4049671A1 (en) | 2004-07-06 | 2022-08-31 | 3D Matrix, Inc. | Purified amphiphilic peptide compositions and uses thereof |
| US9162005B2 (en) * | 2005-04-25 | 2015-10-20 | Arch Biosurgery, Inc. | Compositions for prevention of adhesions and other barrier applications |
| AU2006241123B2 (en) * | 2005-04-25 | 2013-10-03 | Massachusetts Institute Of Technology | Compositions and methods for promoting hemostasis and other physiological activities |
| BRPI0920030B1 (pt) * | 2008-10-06 | 2019-03-26 | 3-D Matrix, Ltd. | Agente de oclusão do tecido, agentes hemostáticos, preventivos e de oclusão ou escleroterapia relacionados, e infusão do tecido mucosal |
| ES2653667T3 (es) * | 2011-09-02 | 2018-02-08 | 3-D Matrix, Ltd. | Péptidos anfifílicos para la oclusión del escape de aire torácico |
| US20160287744A1 (en) * | 2012-11-14 | 2016-10-06 | 3-D Matrix Ltd. | Vascular embolic system |
| EP2968654A1 (en) * | 2013-03-14 | 2016-01-20 | 3-D Matrix, Ltd | Treatment for bile leakage |
| US20210023257A1 (en) | 2016-03-18 | 2021-01-28 | 3-D Matrix, Ltd. | Cerebrospinal fluid leakage occlusion |
| EP3429646A1 (en) | 2016-03-18 | 2019-01-23 | 3-D Matrix, Ltd | Pancreatic fistula occlusion |
| KR20190022455A (ko) | 2016-03-18 | 2019-03-06 | 가부시끼가이샤 쓰리디 매트릭스 | 생물학적 조직 유착을 방지하는 방법 |
-
2017
- 2017-03-17 KR KR1020187030142A patent/KR20190022455A/ko not_active Ceased
- 2017-03-17 WO PCT/IB2017/000312 patent/WO2017158420A1/en not_active Ceased
- 2017-03-17 AU AU2017232540A patent/AU2017232540A1/en not_active Abandoned
- 2017-03-17 BR BR112018068941-6A patent/BR112018068941A2/pt not_active Application Discontinuation
- 2017-03-17 MX MX2018011121A patent/MX2018011121A/es unknown
- 2017-03-17 JP JP2018548904A patent/JP7049557B2/ja active Active
- 2017-03-17 US US16/085,730 patent/US20190091376A1/en not_active Abandoned
- 2017-03-17 CA CA3017684A patent/CA3017684A1/en not_active Abandoned
- 2017-03-17 EP EP17720563.0A patent/EP3429653B1/en active Active
- 2017-03-17 CN CN201780030433.3A patent/CN109152868A/zh active Pending
-
2018
- 2018-09-14 CL CL2018002646A patent/CL2018002646A1/es unknown
-
2021
- 2021-09-03 AU AU2021225225A patent/AU2021225225A1/en not_active Abandoned
- 2021-11-05 US US17/519,638 patent/US20220111126A1/en not_active Abandoned
-
2023
- 2023-02-12 US US18/167,864 patent/US12377196B2/en active Active
-
2025
- 2025-01-30 US US19/041,236 patent/US20250177614A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019508184A5 (enExample) | ||
| JP2024100934A (ja) | 液体送達組成物 | |
| WO2017028025A1 (zh) | 贻贝粘蛋白产品及其抑制粘膜炎症的应用 | |
| JP2001519386A (ja) | 哺乳動物における血管収縮または血管痙攣を予防または緩和するための一酸化窒素供与体組成物、方法、装置およびキット | |
| JP6438406B2 (ja) | 疎水性生理活性物質を送達するための組成物および方法 | |
| JP5954736B2 (ja) | 難治性炎症性腸疾患の予防又は治療方法 | |
| JP6837598B2 (ja) | コラーゲンペプチドに基づく医薬組成物及びデバイス、並びにその製造の方法及び使用 | |
| JP2011528678A5 (enExample) | ||
| JP2023109937A (ja) | ３－置換１，２，４－オキサジアゾールの結晶形態 | |
| Naveed et al. | A novel ventricular restraint device (ASD) repetitively deliver Salvia miltiorrhiza to epicardium have good curative effects in heart failure management | |
| JP2019508175A5 (enExample) | ||
| MX2014003256A (es) | Uso de hidroxamatos de indolilo e indolinilo para tratar insuficiencia cardiaca o lesion neuronal. | |
| WO2024016002A1 (en) | Milk derived exosomes and uses thereof | |
| WO2023028251A1 (en) | Endoscopic, percutaneous and other methods for dissolution of pancreatic necrosis | |
| CN1511032A (zh) | 含有抗肿瘤成分的甲苯磺胺及其用法 | |
| CN105497019A (zh) | 胺类化合物治疗疼痛的医药用途 | |
| TW202035415A (zh) | 用於治療骨關節炎的化合物 | |
| JP5936683B2 (ja) | 癒着の治療及び予防のための化合物、医薬組成物及び方法 | |
| CN101822643A (zh) | 川芎嗪纳米粒及其制备方法和制药中的应用 | |
| US20100305144A1 (en) | Prevention of recurrence of urethral stricture after a conventional treatment | |
| PL235226B1 (pl) | Ksantohumol do zastosowania w leczeniu lub zapobieganiu i profilaktyce chorób hemoroidalnych oraz kompozycja zawierająca ksantohumol | |
| JP2010024170A (ja) | 抗悪性腫瘍剤の腫瘍組織への局所送達増強剤 | |
| RU2328298C1 (ru) | Способ лечения неспецифического язвенного колита | |
| Keller et al. | Phenylephrine-induced epistaxis in a six-year-old Quarter horse with nephrosplenic entrapment | |
| WO2008003013A2 (en) | Antitumorigenic drug combination comprising an hdac inhibitor and a tsp-1 peptidomimetic |